Groundbreaking discoveries using MRI technology to help elevate population health outcomes

Our goal is to help you personalize cancer diagnosis, radiation therapy planning and treatment assessment for every patient. To achieve this, we can provide advanced functional and metabolic imaging information with SIGNA™ PET/MR AIR™⁵ and ODEN* (Oscillating Diffusion Encoding). Our AIR™ RT Suite solution is easy to set up and helps ensure the proper positioning of each patient. And the 32-channel AIR™ Open Coils provide patient comfort while delivering a high signal-to-noise ratio.

Exclusive AI applications like AIR™ Recon DL and MR Contour DL*, our auto-organ segmentation application that generates contours of at-risk organs, provides speed, consistency and accuracy, enabling the delivery of precise radiation therapy treatments.⁶This advanced hardware runs on our latest MR 30 for SIGNA release, found across all of our SIGNA scanners. This platform features AIR Recon DL, our pioneering deep-learning-based reconstruction algorithm that enables you to achieve pin-sharp image quality quicker than ever before. This makes the SIGNA PET/MR AIR incredibly powerful.

We're committed to enhancing your understanding of the brain as well as enable the discovery and application of new treatment pathways for life-altering neurodegenerative diseases.

MotionFree Brain, available on SIGNA™ PET/MR AIR™, helps to significantly improve the visualization and quantitation of PET tracers that link to biochemicals associated with Alzheimer’s Disease, without any external devices.

Our ARIA imaging protocols help monitor and evaluate Amyloid Related Imaging Abnormalities for patients receiving beta-amyloid treatments for Alzheimer's Disease.

Unlock new insights into brain function with SIGNA™ MAGNUS*, our dedicated head-only MRI scanner. Push the boundaries of neurological research with the advanced capabilities of our SIGNA™ 7T⁷ scanner.

As a leader in AI-enabled MRI solutions, SIGNA™ MR has introduced several groundbreaking AI-based applications to the market in just 7 years.

These applications include innovations in MRI protocol planning, acceleration, reconstruction and visualization. All designed to enhance the MRI experience for everyone. And this is only the beginning.

With over 500 GE HealthCare MRI research studies underway globally, we actively collaborate with world-class healthcare providers and research institutions to help provide innovations that translate research discovery into clinical adoption, enabling leading-edge care.

By working closely with these organizations and collaborators, we are constantly building upon our collective strengths and pushing the boundaries of our shared knowledge. This infrastructure of excellence allows us all to help accelerate the development and clinical translation of advanced MRI technologies.

These collaborations help equip clinicians with technology to precisely diagnose and treat medical conditions, elevate theranostic care, reduce scan times and enhance the patient experience at each step of their journey.